Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis.

ABSTRACT:

Background

Patients with inflammatory arthritis (IA), defined as rheumatoid arthritis (RA) and psoriatic arthritis (PsA), are at increased risk for cardiovascular disease (CVD). The frequency of screening and treatment of hyperlipidemia, a modifiable CVD risk factor, is low in these patients. The reasons for low screening and treatment rates in this population are poorly understood. Our objective was to elicit the barriers and facilitators for screening and treatment of hyperlipidemia from the perspective of patients with IA.

Methods

We conducted a qualitative study using focus groups of patients with IA, guided by Bandura's Social Cognitive Theory. We recruited patients with IA aged 40 years and older from a single academic center. Data were analyzed thematically.

Result

SUBMITTER: Navarro-Millan I 

PROVIDER: S-EPMC7265623 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature